OncWeekly Content Page - Page 334

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

Durvalumab ± Tremelimumab + Chemo in First-Line Metastatic NSCLC: POSEIDON Study

Jun 08, 2023

Lung Cancer,NSCLC (Non-Small Cell Lung Cancer)

FDA Approval Summary: Nivolumab Plus Chemo for Neoadjuvant Treatment in Resectable NSCLC

Jun 08, 2023

Lymphoma,Other Cancers

Enhancing Hodgkin Lymphoma Treatment: Pembrolizumab with Chemotherapy in Newly Diagnosed Patients

Jun 08, 2023

Lymphoma,Other Cancers

Improved Treatment for High-Risk Pediatric Hodgkin's Lymphoma: Brentuximab Vedotin and Chemotherapy

Jun 08, 2023

Advertisement

Other Cancers

Enhancing Myelofibrosis Treatment: Combining Navitoclax with Ruxolitinib

Jun 08, 2023

Breast Cancer

Alpelisib+Fulvestrant vs. Real-World Standard Treatment for HR+, HER2-, PIK3CA-Mutated Breast Cancer

Jun 08, 2023

Other Cancers

Systemic Corticosteroids' Impact on Survival in Metastatic Uveal Melanoma

Jun 02, 2023

Genitourinary Cancer,Other Cancers

Enzalutamide's Impact on QoL in Metastatic Hormone-Sensitive Prostate Cancer

Jun 02, 2023

Previous
1
…
332
333
334
335
336
…
400
Next

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Advertisement